ASTRAZENECA DL-,25 SP.ADR/ US0463531089 /
16/05/2024 8:08:21 | Diferencia -0.50 | Volumen | Bid18:56:05 | Ask18:56:05 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
70.50EUR | -0.70% | 0 Volumen de negocios: 0.00 |
70.50Volumen de oferta: 360 | 71.00Tamaño/ Volumen/ Formato de Ask: 360 | 219.7 mil millonesEUR | - | - |
GlobeNewswire
4:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sha...
GlobeNewswire
4:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lin...
GlobeNewswire
4:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mal...
GlobeNewswire
4:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Qui...
GlobeNewswire
4:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hir...
GlobeNewswire
2:01
Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds The Chemours Company Shareholders of ...
GlobeNewswire
2:00
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sonder Holdings Inc. Investors to Secure Counsel Before ...
GlobeNewswire
2:00
HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data ...
GlobeNewswire
1:57
Genco Shipping & Trading Issues Statement Regarding George Economou’s Withdrawal of his Nominee
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página